Showing results (11-20 of 48) with videos related to
Sort By:
Pageof 5
Biological Psychiatry|August 25, 1999
Tryptophan depletion and depressive vulnerabilityF A Moreno, A J Gelenberg, G R Heninger, et al.Biological Psychiatry|July 27, 1999
Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant actionP L Delgado, H L Miller, R M Salomon, et al.Drugs of Today (Barcelona, Spain : 1998)|September 16, 2003
Reboxetine: a review of efficacy and tolerabilityP L Delgado, T MichaelsPharmacopsychiatry|January 1, 1996
The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humansG R Heninger, P L Delgado, D S CharneyInternational Clinical Psychopharmacology|November 1, 1993
The use of tryptophan depletion to evaluate central serotonin function in depression and other neuropsychiatric disordersR M Salomon, H L Miller, P L Delgado, et al.Archives of General Psychiatry|January 1, 1989
Lithium treatment and serotoninergic function. Neuroendocrine and behavioral responses to intravenous tryptophan in affective disorderL H Price, D S Charney, P L Delgado, et al.The American Journal of Psychiatry|November 1, 1991
Serotonin function and depression: neuroendocrine and mood responses to intravenous L-tryptophan in depressed patients and healthy comparison subjectsL H Price, D S Charney, P L Delgado, et al.The Journal of Clinical Psychiatry|December 1, 1990
The effect of long-term imipramine treatment on carbon dioxide-induced anxiety in panic disorder patientsS W Woods, D S Charney, P L Delgado, et al.The Journal of Clinical Psychiatry|April 1, 1988
Sequence of drug administration in lithium augmentation: a case studyL H Price, P L Delgado, D S Charney, et al.Journal of Affective Disorders|July 1, 1988
Efficacy of fluvoxamine in treatment-refractory depressionP L Delgado, L H Price, D S Charney, et al.Pageof 5